Cargando…
TSH Receptor Signaling Abrogation by a Novel Small Molecule
Pathological activation of the thyroid-stimulating hormone receptor (TSHR) is caused by thyroid-stimulating antibodies in patients with Graves’ disease (GD) or by somatic and rare genomic mutations that enhance constitutive activation of the receptor influencing both G protein and non-G protein sign...
Autores principales: | Latif, Rauf, Realubit, Ronald B., Karan, Charles, Mezei, Mihaly, Davies, Terry F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037132/ https://www.ncbi.nlm.nih.gov/pubmed/27729899 http://dx.doi.org/10.3389/fendo.2016.00130 |
Ejemplares similares
-
A Gq Biased Small Molecule Active at the TSH Receptor
por: Latif, Rauf, et al.
Publicado: (2020) -
Brief Report - Monoclonal Antibodies Illustrate the Difficulties in Measuring Blocking TSH Receptor Antibodies
por: Davies, Terry F., et al.
Publicado: (2022) -
Computational model of the full-length TSH receptor
por: Mezei, Mihaly, et al.
Publicado: (2022) -
OR03-06 Transmembrane Water Channels Within The Tsh Receptor
por: Latif, Rauf, et al.
Publicado: (2023) -
Editorial: TSH Receptor and Autoimmunity
por: Davies, Terry F., et al.
Publicado: (2019)